Cannabis News Box

FDA gives positive review for GW Pharmaceuticals’ cannabis-based medicine Epidiolex

FDA gives positive review for GW Pharmaceuticals’ cannabis-based medicine Epidiolex

Bethan Rose Jenkins, Cannabis News Writer/Editorial

April 19, 2018

Epidiolex, a cannabis-based treatment for epilepsy from GW Pharmaceuticals, received a positive review from staff at the Federal Drug Administration (FDA) on Tuesday. GW Pharmaceuticals provided “substantial evidence” to prove the drug’s suitability for treating two rare types of epilepsy. ...

Public Health Care & Human Services Committee